| TTM
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
12/31/2021
|
|
|---|---|---|---|---|---|
| Total Revenue
|
116,233 | 120,228 | 32,840 | 102,438 | 126,133 |
|
Cost of Revenue
|
-144,659 | -148,706 | -48,049 | -56,525 | -69,310 |
|
Gross Profit
|
-28,426 | -28,478 | -15,209 | 45,913 | 56,823 |
| Selling, General and Administrative Expenses
|
-91,092 | -98,006 | -35,723 | -38,437 | -28,877 |
|
Research and Development Expenses
|
-35,867 | -35,033 | -24,195 | -26,845 | -40,921 |
|
Operating Income/Expenses
|
-124,862 | -133,039 | -59,918 | -65,282 | -69,798 |
|
Total Operating Profit/Loss
|
-153,288 | -161,517 | -75,127 | -19,369 | -12,975 |
| Total Net Finance Income/Expense
|
1,022 | 5,642 | 11,740 | 578 | -1,777 |
| Net Investment Income
|
-5,510 | 16,747 | 992 | 37,399 | -21,627 |
| Irregular Income/Expenses
|
-15,300 | -15,300 | 0 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
1,770 | 1,711 | 385 | 2,844 | 7,166 |
|
Non-Operating Income/Expenses, Total
|
-18,018 | 8,800 | 13,117 | 40,821 | -16,238 |
|
Pretax Income
|
-171,308 | -152,717 | -62,010 | 21,452 | -29,213 |
|
Provision for Income Tax
|
820 | 771 | -1,019 | -6,429 | -1,298 |
|
Net Income from Continuing Operations
|
-170,488 | -151,946 | -63,029 | 15,023 | -30,511 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-170,488 | -151,946 | -63,029 | 15,023 | -30,511 |
|
Non-Controlling/Minority Interests
|
31,332 | 31,332 | 13,003 | -194 | 19,067 |
|
Net Income after Non-Controlling/Minority Interests
|
-139,156 | -120,614 | -50,026 | 14,829 | -11,444 |
|
Net Income Available to Common Stockholders
|
-139,156 | -120,614 | -50,026 | 14,829 | -11,444 |
|
Diluted Net Income Available to Common Stockholders
|
-139,156 | -120,614 | -50,026 | 14,829 | -11,444 |
| Basic EPS
|
-3.87 | -3.21 | -1.66 | 0.49 | -0.38 |
| Diluted EPS
|
-3.87 | -3.21 | -1.66 | 0.49 | -0.38 |
|
Basic Weighted Average Shares Outstanding
|
37,595.0200 | 37,595.0200 | 30,160.3740 | 30,160.3740 | 30,160.3740 |
|
Diluted Weighted Average Shares Outstanding
|
37,595.0200 | 37,595.0200 | 30,160.3740 | 30,160.3740 | 30,160.3740 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-172,330 | -158,359 | -73,750 | 20,874 | -27,436 |
|
EBITDA
|
-172,330 | -135,124 | -49,353 | 45,679 | 9,486 |
|
Normalized EBITDA
|
-157,030 | -100,023 | -49,323 | 50,772 | 9,486 |
|
Normalized Income
|
-155,261.2411 | -117,022.2249 | -62,999 | 18,589.6686 | -30,511 |
|
Total Unusual Items
|
15,300 | 35,101 | 30 | 5,093 | 0 |
12/31/2021 - 2/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade